secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2022-09-08T23:59:59+00:00
Accession:  0000055529-22-000014
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific Q1 FY2023 net loss narrows to $0.27/share; sales up 27% YoY
-------------------------------------------------------------------------------

- Sales $50.1M, up 26.9% YoY from $39.5M; net loss of $747K vs $1.35M loss a year earlier.
- Diluted EPS loss $0.27 vs loss $0.48; EBITDA improved to $275K from -$342K.
- Order backlog $174M, a record for fourth time in five quarters, up from $120.6M a year ago.
- Domestic segment swung to net income of $98K from loss; International net income rose to $687K.
- Cash $21.5M; no short-term debt; long-term debt $29.5M; debt-to-equity 1.09-to-1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552922000014/0000055529-22-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552922000014/kequ-20220908.htm
  HTML page:      https://secwatch.observer/filing/0000055529-22-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer